Pharmacological management of mild or moderate persistent asthma
- 1 August 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 368 (9537) , 794-803
- https://doi.org/10.1016/s0140-6736(06)69289-1
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Inflammatory subtypes in asthma: Assessment and identification using induced sputumRespirology, 2006
- Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthmaJournal of Allergy and Clinical Immunology, 2005
- Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC StudyPublished by American Academy of Pediatrics (AAP) ,2005
- Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent AsthmaJournal of Asthma, 2004
- A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammationJournal of Allergy and Clinical Immunology, 2000
- Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthmaThorax, 2000
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- Regular versus symptomatic aerosol bronchodilator treatment of asthmaRespiratory Medicine, 1981